The Chemokine CXCL1/Growth Related Oncogene Increases Sodium Currents and Neuronal Excitability in Small Diameter Sensory Neurons

Background: Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root g...

Full description

Saved in:
Bibliographic Details
Published inMolecular pain Vol. 4; no. 1; p. 38
Main Authors Wang, Jun-Gang, Strong, Judith A, Xie, Wenrui, Yang, Rui-Hua, Coyle, Dennis E, Wick, Dayna M, Dorsey, Ericka D, Zhang, Jun-Ming
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 24.09.2008
BioMed Central Ltd
BioMed Central
SAGE Publishing
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is known about its direct effects on neurons. Results: We report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of Na+ currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2-to 4 fold, without altered voltage dependence or kinetic changes. These effects required long exposures, and were completely blocked by co-incubation with protein synthesis inhibitor cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel isoforms were predominant both before and after GRO/KC treatment (Nav 1.1, 1.7, and 1.8). TTX-sensitive isoforms 1.1 and 1.7 significantly increased 2 – 3 fold after GRO/KC incubation, while 1.8 showed a trend towards increased expression. Current clamp experiments showed that GRO/KC caused a marked increase in excitability, including resting potential depolarization, decreased rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire repetitively; IB4-positive cells also showed marked broadening of action potentials. Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS. Conclusion: Many studies on the role of chemokines in pain conditions have focused on their rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis.
AbstractList BACKGROUNDAltered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is known about its direct effects on neurons.RESULTSWe report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of Na+ currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2- to 4 fold, without altered voltage dependence or kinetic changes. These effects required long exposures, and were completely blocked by co-incubation with protein synthesis inhibitor cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel isoforms were predominant both before and after GRO/KC treatment (Nav 1.1, 1.7, and 1.8). TTX-sensitive isoforms 1.1 and 1.7 significantly increased 2 - 3 fold after GRO/KC incubation, while 1.8 showed a trend towards increased expression. Current clamp experiments showed that GRO/KC caused a marked increase in excitability, including resting potential depolarization, decreased rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire repetitively; IB4-positive cells also showed marked broadening of action potentials. Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS.CONCLUSIONMany studies on the role of chemokines in pain conditions have focused on their rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis.
Background: Altered Na + channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is known about its direct effects on neurons. Results: We report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of Na + currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2-to 4 fold, without altered voltage dependence or kinetic changes. These effects required long exposures, and were completely blocked by co-incubation with protein synthesis inhibitor cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel isoforms were predominant both before and after GRO/KC treatment (Na v 1.1, 1.7, and 1.8). TTX-sensitive isoforms 1.1 and 1.7 significantly increased 2 – 3 fold after GRO/KC incubation, while 1.8 showed a trend towards increased expression. Current clamp experiments showed that GRO/KC caused a marked increase in excitability, including resting potential depolarization, decreased rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire repetitively; IB4-positive cells also showed marked broadening of action potentials. Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS. Conclusion: Many studies on the role of chemokines in pain conditions have focused on their rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis.
BACKGROUND: Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is known about its direct effects on neurons. RESULTS: We report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of Na+ currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2- to 4 fold, without altered voltage dependence or kinetic changes. These effects required long exposures, and were completely blocked by co-incubation with protein synthesis inhibitor cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel isoforms were predominant both before and after GRO/KC treatment (Nav 1.1, 1.7, and 1.8). TTX-sensitive isoforms 1.1 and 1.7 significantly increased 2 - 3 fold after GRO/KC incubation, while 1.8 showed a trend towards increased expression. Current clamp experiments showed that GRO/KC caused a marked increase in excitability, including resting potential depolarization, decreased rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire repetitively; IB4-positive cells also showed marked broadening of action potentials. Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS. CONCLUSION: Many studies on the role of chemokines in pain conditions have focused on their rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis.
Background: Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is known about its direct effects on neurons. Results: We report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of Na+ currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2-to 4 fold, without altered voltage dependence or kinetic changes. These effects required long exposures, and were completely blocked by co-incubation with protein synthesis inhibitor cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel isoforms were predominant both before and after GRO/KC treatment (Nav 1.1, 1.7, and 1.8). TTX-sensitive isoforms 1.1 and 1.7 significantly increased 2 – 3 fold after GRO/KC incubation, while 1.8 showed a trend towards increased expression. Current clamp experiments showed that GRO/KC caused a marked increase in excitability, including resting potential depolarization, decreased rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire repetitively; IB4-positive cells also showed marked broadening of action potentials. Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS. Conclusion: Many studies on the role of chemokines in pain conditions have focused on their rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis.
Abstract Background Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is known about its direct effects on neurons. Results We report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of Na+ currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2- to 4 fold, without altered voltage dependence or kinetic changes. These effects required long exposures, and were completely blocked by co-incubation with protein synthesis inhibitor cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel isoforms were predominant both before and after GRO/KC treatment (Nav 1.1, 1.7, and 1.8). TTX-sensitive isoforms 1.1 and 1.7 significantly increased 2 – 3 fold after GRO/KC incubation, while 1.8 showed a trend towards increased expression. Current clamp experiments showed that GRO/KC caused a marked increase in excitability, including resting potential depolarization, decreased rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire repetitively; IB4-positive cells also showed marked broadening of action potentials. Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS. Conclusion Many studies on the role of chemokines in pain conditions have focused on their rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis.
Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is known about its direct effects on neurons. We report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of Na+ currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2- to 4 fold, without altered voltage dependence or kinetic changes. These effects required long exposures, and were completely blocked by co-incubation with protein synthesis inhibitor cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel isoforms were predominant both before and after GRO/KC treatment (Nav 1.1, 1.7, and 1.8). TTX-sensitive isoforms 1.1 and 1.7 significantly increased 2 - 3 fold after GRO/KC incubation, while 1.8 showed a trend towards increased expression. Current clamp experiments showed that GRO/KC caused a marked increase in excitability, including resting potential depolarization, decreased rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire repetitively; IB4-positive cells also showed marked broadening of action potentials. Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS. Many studies on the role of chemokines in pain conditions have focused on their rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis.
Author Yang, Rui-Hua
Coyle, Dennis E
Dorsey, Ericka D
Strong, Judith A
Zhang, Jun-Ming
Wick, Dayna M
Wang, Jun-Gang
Xie, Wenrui
AuthorAffiliation 1 Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0531, USA
AuthorAffiliation_xml – name: 1 Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0531, USA
Author_xml – sequence: 1
  givenname: Jun-Gang
  surname: Wang
  fullname: Wang, Jun-Gang
  email: jungang.wang@uchsc.edu
  organization: Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267–0531, USA
– sequence: 2
  givenname: Judith A
  surname: Strong
  fullname: Strong, Judith A
  email: judith.strong@uc.edu
  organization: Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267–0531, USA
– sequence: 3
  givenname: Wenrui
  surname: Xie
  fullname: Xie, Wenrui
  email: xiewe@uc.edu
  organization: Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267–0531, USA
– sequence: 4
  givenname: Rui-Hua
  surname: Yang
  fullname: Yang, Rui-Hua
  email: rui-hua.yang@uc.edu
  organization: Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267–0531, USA
– sequence: 5
  givenname: Dennis E
  surname: Coyle
  fullname: Coyle, Dennis E
  email: dennis.coyle@uc.edu
  organization: Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267–0531, USA
– sequence: 6
  givenname: Dayna M
  surname: Wick
  fullname: Wick, Dayna M
  email: dayna.wick@oberlin.edu
  organization: Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267–0531, USA
– sequence: 7
  givenname: Ericka D
  surname: Dorsey
  fullname: Dorsey, Ericka D
  email: dorseye@uc.edu
  organization: Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267–0531, USA
– sequence: 8
  givenname: Jun-Ming
  surname: Zhang
  fullname: Zhang, Jun-Ming
  email: jun-ming.zhang@uc.edu
  organization: Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267–0531, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18816377$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1v1DAQhiNURD_gyhH5xAWljWOvY1-QqqWUlVZUYovEzfLHZNdLYrd2AuyRf05CVqUr1JNH8756ZsYzp9mRDx6y7DUuzjHm7AJXlOa8YCKnOeHPspOHxNGj-Dg7TWlbFKQqGH6RHWPOMSNVdZL9vt0Amm-gDd-dH6Jv8yW-uI7hZ7dBX6BRHVh0401Yw6AuvImgEiS0Ctb1LZr3MYLvElLeos_Qx-BVg65-Gdcp7RrX7ZDzaNWqpkEfnGqhg4hW4FOIu70_vcye16pJ8Gr_nmVfP17dzj_ly5vrxfxymWtGRJdzRmmthcEzymaEQGkEYMDUYsvAcDNMQ2pjK15Wpa2tsnymCyCmNppqhjU5yxYT1wa1lXfRtSruZFBO_k2EuJYqds40IKGCWptCCwIVZVTxekCJGkwlaKkEH1jvJ9Zdr1uwZviDqJoD6KHi3Uauww9ZzlgpBBkAlxNAu_AE4FAxoZXjOuW4TkklGZt4u28ihvseUidblww0jfIQ-iSZYLSoirHY-WQ0MaQUoX6ogws5XtH_5DePx_tn35_NYHg3GZJag9yGPg57T0_h_gDwd9We
CitedBy_id crossref_primary_10_1007_s11033_022_07591_y
crossref_primary_10_1097_01_j_pain_0000460322_72396_53
crossref_primary_10_3389_fnmol_2023_1336664
crossref_primary_10_1016_j_jpain_2014_05_003
crossref_primary_10_1177_1744806917726256
crossref_primary_10_1016_j_phrs_2015_11_005
crossref_primary_10_3390_biom12060818
crossref_primary_10_1163_15707563_00002502
crossref_primary_10_1016_j_lfs_2017_09_041
crossref_primary_10_1523_JNEUROSCI_3386_11_2011
crossref_primary_10_1016_j_neuroscience_2012_01_007
crossref_primary_10_1186_1744_8069_7_74
crossref_primary_10_1172_JCI92117
crossref_primary_10_1016_j_bbi_2010_12_014
crossref_primary_10_1016_j_nbd_2021_105468
crossref_primary_10_3389_fncel_2017_00263
crossref_primary_10_3390_biomedicines10081946
crossref_primary_10_7554_eLife_54693
crossref_primary_10_3892_ijo_2015_3203
crossref_primary_10_1016_j_it_2017_12_003
crossref_primary_10_1097_j_pain_0000000000001903
crossref_primary_10_1159_000486865
crossref_primary_10_3390_ijms23084205
crossref_primary_10_1016_j_neulet_2019_134533
crossref_primary_10_1089_aivt_2018_0007
crossref_primary_10_1152_ajpheart_00414_2009
crossref_primary_10_3389_fphar_2022_854238
crossref_primary_10_1016_j_ebiom_2019_04_032
crossref_primary_10_1136_annrheumdis_2015_208308
crossref_primary_10_1152_ajprenal_00189_2015
crossref_primary_10_1016_j_expneurol_2014_05_014
crossref_primary_10_1038_s41467_024_47640_7
crossref_primary_10_1007_s12264_012_1208_8
crossref_primary_10_1152_ajprenal_00011_2012
crossref_primary_10_3109_08977190903299387
crossref_primary_10_1016_j_cyto_2022_156005
crossref_primary_10_1016_j_pain_2013_07_002
crossref_primary_10_1002_ana_26627
crossref_primary_10_1016_j_pharmthera_2020_107581
crossref_primary_10_1186_1742_2094_11_38
crossref_primary_10_1186_1744_8069_5_26
crossref_primary_10_1111_jcmm_12268
crossref_primary_10_1111_joor_13273
crossref_primary_10_1007_s00424_023_02852_6
crossref_primary_10_1177_1744806916646381
crossref_primary_10_1007_s11011_013_9471_6
crossref_primary_10_1136_bmj_m754
crossref_primary_10_1016_j_brainresbull_2016_09_016
crossref_primary_10_1097_j_pain_0000000000001333
crossref_primary_10_3389_fnsyn_2021_637549
crossref_primary_10_1186_s12974_015_0441_2
crossref_primary_10_1371_journal_pone_0055391
crossref_primary_10_1111_papr_13051
crossref_primary_10_1186_1742_2094_9_189
crossref_primary_10_3390_ijms232012389
crossref_primary_10_3389_adar_2022_10848
crossref_primary_10_3390_ijms23136917
crossref_primary_10_3389_fpain_2021_698157
crossref_primary_10_1136_annrheumdis_2015_208094
crossref_primary_10_1016_j_nbd_2017_06_001
crossref_primary_10_1177_00220345211004872
crossref_primary_10_1186_1744_8069_9_17
crossref_primary_10_1016_j_intimp_2023_110330
crossref_primary_10_1016_j_pain_2011_09_009
crossref_primary_10_1016_j_neulet_2013_10_004
crossref_primary_10_1126_scitranslmed_3002193
crossref_primary_10_1097_PR9_0000000000000905
crossref_primary_10_1055_a_1203_1192
crossref_primary_10_1177_17448069231169373
crossref_primary_10_1016_j_neuroscience_2011_12_045
Cites_doi 10.4049/jimmunol.158.6.2882
10.1016/j.neuroscience.2005.05.046
10.1016/S0165-5728(99)00266-0
10.1016/S0169-328X(99)00070-4
10.1016/j.mcn.2004.01.015
10.1016/j.neuroscience.2006.06.045
10.1016/j.brainres.2004.09.051
10.1096/fj.06-6077fje
10.1093/nar/gng073
10.1038/sj.bjp.0702329
10.4049/jimmunol.165.2.1044
10.1016/S0165-3806(01)00128-6
10.1523/JNEUROSCI.19-24-j0001.1999
10.1016/j.jpain.2006.06.010
10.1152/jn.00509.2005
10.1139/y05-127
10.1002/jnr.10744
10.1016/j.ejpain.2008.02.003
10.1080/13550280290100932
10.1523/JNEUROSCI.21-14-05027.2001
10.1038/labinvest.3700208
10.1111/j.1460-9568.2005.04186.x
10.1002/jnr.20612
10.1254/jjp.88.365
10.1002/jnr.10503
10.1073/pnas.95.24.14500
10.1097/01.anes.0000278907.37774.8d
10.1177/1073858403259950
10.1016/j.nbd.2005.11.015
10.1523/JNEUROSCI.3858-05.2006
10.1097/01.anes.0000270761.99469.a7
10.1016/j.neulet.2003.12.007
10.1016/j.pharmthera.2006.04.001
10.1016/j.pain.2007.07.026
10.1007/s00424-004-1315-0
ContentType Journal Article
Copyright 2008 Wang et al; licensee BioMed Central Ltd.
Copyright © 2008 Wang et al; licensee BioMed Central Ltd. 2008 Wang et al; licensee BioMed Central Ltd.
Copyright_xml – notice: 2008 Wang et al; licensee BioMed Central Ltd.
– notice: Copyright © 2008 Wang et al; licensee BioMed Central Ltd. 2008 Wang et al; licensee BioMed Central Ltd.
DBID AFRWT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1186/1744-8069-4-38
DatabaseName SAGE Open Access Journals
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef



MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: AFRWT
  name: SAGE Open Access Journals
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1744-8069
EndPage 38
ExternalDocumentID oai_doaj_org_article_e7efbc0b93e7464a8fb0e9fec7942a98
oai_biomedcentral_com_1744_8069_4_38
10_1186_1744_8069_4_38
18816377
10.1186_1744-8069-4-38
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: R01 NS045594-05
– fundername: NINDS NIH HHS
  grantid: R01 NS055860
– fundername: NINDS NIH HHS
  grantid: R01 NS045594
– fundername: NINDS NIH HHS
  grantid: NS55860
– fundername: NINDS NIH HHS
  grantid: NS45594
– fundername: NINDS NIH HHS
  grantid: R01 NS045594-04
– fundername: NINDS NIH HHS
  grantid: R01 NS055860-01A2
GroupedDBID ---
-A0
0R~
123
29M
2VQ
2WC
31X
4.4
53G
54M
5VS
AAJPV
AATBZ
ABAWP
ABDBF
ABHFT
ABIVO
ABNCE
ABQXT
ACARO
ACGFO
ACGFS
ACGZU
ACIHN
ACPRK
ACRMQ
ACROE
ACSIQ
ADBBV
ADINQ
ADOGD
ADRAZ
ADUKV
AEAQA
AENEX
AEWDL
AEWHI
AFCOW
AFGXO
AFKRG
AFRWT
AHBYD
AHMBA
AHSBF
AHYZX
AIOMO
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
AUTPY
AYAKG
BAWUL
BCNDV
BDDNI
BFQNJ
BMC
C24
C6C
CS3
DC.
DIK
DU5
DV7
E3Z
EBD
EBS
EJD
EMOBN
ESX
F5P
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
HH5
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
J8X
K.F
KQ8
M48
M~E
O5R
O5S
O9-
OK1
P2P
RBZ
RIG
RNS
ROL
RPM
RSV
SFC
SFK
SFT
SGV
SMD
SOJ
SPP
SV3
TR2
TUS
WOQ
WOW
XSB
~8M
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
CITATION
7X8
ABVAZ
AFNRJ
5PM
ID FETCH-LOGICAL-b639t-8644fb9c1546533e2c9e1e14d1d6ec8c3773fcd78272dfdad85b0e3cfcb4b61b3
IEDL.DBID RPM
ISSN 1744-8069
IngestDate Thu Sep 05 15:30:32 EDT 2024
Tue Sep 17 21:35:18 EDT 2024
Wed May 22 07:11:15 EDT 2024
Fri Aug 16 07:50:02 EDT 2024
Wed Oct 02 14:36:11 EDT 2024
Sat Sep 28 07:46:19 EDT 2024
Tue Jul 16 20:50:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b639t-8644fb9c1546533e2c9e1e14d1d6ec8c3773fcd78272dfdad85b0e3cfcb4b61b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562993/
PMID 18816377
PQID 69640703
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_e7efbc0b93e7464a8fb0e9fec7942a98
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2562993
biomedcentral_primary_oai_biomedcentral_com_1744_8069_4_38
proquest_miscellaneous_69640703
crossref_primary_10_1186_1744_8069_4_38
pubmed_primary_18816377
sage_journals_10_1186_1744_8069_4_38
PublicationCentury 2000
PublicationDate 2008-09-24
PublicationDateYYYYMMDD 2008-09-24
PublicationDate_xml – month: 09
  year: 2008
  text: 2008-09-24
  day: 24
PublicationDecade 2000
PublicationPlace Los Angeles, CA
PublicationPlace_xml – name: Los Angeles, CA
– name: United States
PublicationTitle Molecular pain
PublicationTitleAlternate Mol Pain
PublicationYear 2008
Publisher SAGE Publications
BioMed Central Ltd
BioMed Central
SAGE Publishing
Publisher_xml – name: SAGE Publications
– name: BioMed Central Ltd
– name: BioMed Central
– name: SAGE Publishing
References Liu, Yang, Liedtke, Simon 2006; 95
Ragozzino 2002; 8
Verri, Cunha, Parada, Poole, Cunha, Ferreira 2006; 112
Fjell, Cummins, Dib-Hajj, Fried, Black, Waxman 1999; 67
Xia, Qin, McNamara, Mackay, Hyman 1997; 150
Peirson, Butler, Foster 2003; 31
Meucci, Fatatis, Simen, Bushell, Gray, Miller 1998; 95
de Kok, Roelofs, Giesendorf, Pennings, Waas, Feuth, Swinkels, Span 2005; 85
Watkins, Milligan, Maier 2003; 521
Ogata, Ohishi 2002; 88
DeLeo, Tanga, Tawfik 2004; 10
Wang, Strong, Xie, Zhang 2007; 107
Cunha, Verri, Valerio, Guerrero, Nogueira, Vieira, Souza, Teixeira, Poole, Ferreira, Cunha 2008; 12
Li, Xie, Strong, Zhang 2007; 107
Moalem, Grafe, Tracey 2005; 134
Coste, Osorio, Padilla, Crest, Delmas 2004; 26
Ludwig, Ehlert, Flad, Brandt 2000; 165
Sommer, Kress 2004; 361
Jin, Gereau 2006; 26
Rozen, Skaletsky 2000; 132
Wu, Pan 2004; 1029
Danik, Puma, Quirion, Williams 2003; 74
Xie, Deng, Li, Bowen, Strong, Zhang 2006; 142
Maruyama, Yamamoto, Matsutomi, Zheng, Nakata, Wood, Ogata 2004; 449
Horuk, Martin, Wang, Schweitzer, Gerassimides, Guo, Lu, Hesselgesser, Perez, Kim, Parker, Hadley, Peiper 1997; 158
Bacon, Harrison 2000; 104
Qin, Wan, Wang 2005; 82
Xiong, Boyle, Winkelbauer, Gorantla, Zheng, Ghorpade, Persidsky, Carlson, Gendelman 2003; 71
Cummins, Dib-Hajj, Black, Akopian, Wood, Waxman 1999; 19
Rush, Craner, Kageyama, Dib-Hajj, Waxman, Ranscht 2005; 22
Oh, Tran, Gillard, Hurley, Hammond, Miller 2001; 21
Cummins, Sheets, Waxman 2007; 131
Loram, Fuller, Fick, Cartmell, Poole, Mitchell 2007; 8
Rittner, Labuz, Schaefer, Mousa, Schulz, Schafer, Stein, Brack 2006; 20
Valles, Grijpink-Ongering, de Bree, Tuinstra, Ronken 2006; 22
Nguyen, Stangel 2001; 128
Gobeil, Fortier, Zhu, Bossolasco, Leduc, Grandbois, Heveker, Bkaily, Chemtob, Barbaz 2006; 84
Hall, Beresford, Browning, Giles 1999; 126
12548717 - J Neurosci Res. 2003 Feb 15;71(4):600-7
15290301 - Pflugers Arch. 2004 Oct;449(1):76-87
10188995 - Br J Pharmacol. 1999 Feb;126(3):810-8
14515358 - J Neurosci Res. 2003 Oct 15;74(2):286-95
16319216 - J Neurophysiol. 2006 Mar;95(3):1478-90
16730375 - Pharmacol Ther. 2006 Oct;112(1):116-38
17667578 - Anesthesiology. 2007 Aug;107(2):322-32
12476350 - J Neurovirol. 2002 Dec;8(6):559-72
16047385 - J Neurosci Res. 2005 Oct 1;82(1):51-62
10878382 - J Immunol. 2000 Jul 15;165(2):1044-52
16039795 - Neuroscience. 2005;134(4):1399-411
16902576 - Can J Physiol Pharmacol. 2006 Mar-Apr;84(3-4):287-97
15135924 - Neurosci Lett. 2004 May 6;361(1-3):184-7
16472549 - Neurobiol Dis. 2006 May;22(2):312-22
10216225 - Brain Res Mol Brain Res. 1999 Apr 20;67(2):267-82
12046980 - Jpn J Pharmacol. 2002 Apr;88(4):365-77
16399694 - J Neurosci. 2006 Jan 4;26(1):246-55
16887276 - Neuroscience. 2006 Oct 27;142(3):809-22
9826729 - Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14500-5
12853650 - Nucleic Acids Res. 2003 Jul 15;31(14):e73
10547847 - Methods Mol Biol. 2000;132:365-86
17766042 - Pain. 2007 Oct;131(3):243-57
17060402 - FASEB J. 2006 Dec;20(14):2627-9
10683519 - J Neuroimmunol. 2000 Apr 3;104(1):92-7
11356265 - Brain Res Dev Brain Res. 2001 May 31;128(1):77-81
12617561 - Adv Exp Med Biol. 2003;521:1-21
15543203 - Lab Invest. 2005 Jan;85(1):154-9
15542080 - Brain Res. 2004 Dec 17;1029(2):251-8
9094983 - Am J Pathol. 1997 Apr;150(4):1267-74
15121184 - Mol Cell Neurosci. 2004 May;26(1):123-34
16949880 - J Pain. 2007 Feb;8(2):127-36
14987447 - Neuroscientist. 2004 Feb;10(1):40-52
10594087 - J Neurosci. 1999 Dec 15;19(24):RC43
11438578 - J Neurosci. 2001 Jul 15;21(14):5027-35
17721250 - Anesthesiology. 2007 Sep;107(3):469-77
18372199 - Eur J Pain. 2008 Nov;12(8):1059-68
16029194 - Eur J Neurosci. 2005 Jul;22(1):39-49
9058825 - J Immunol. 1997 Mar 15;158(6):2882-90
bibr35-1744-8069-4-38
bibr27-1744-8069-4-38
bibr5-1744-8069-4-38
bibr19-1744-8069-4-38
bibr30-1744-8069-4-38
bibr14-1744-8069-4-38
bibr1-1744-8069-4-38
bibr36-1744-8069-4-38
bibr21-1744-8069-4-38
bibr23-1744-8069-4-38
bibr15-1744-8069-4-38
Horuk R (bibr11-1744-8069-4-38) 1997; 158
bibr28-1744-8069-4-38
bibr7-1744-8069-4-38
Xia M (bibr12-1744-8069-4-38) 1997; 150
bibr37-1744-8069-4-38
bibr6-1744-8069-4-38
Rozen S (bibr26-1744-8069-4-38) 2000; 132
bibr2-1744-8069-4-38
bibr20-1744-8069-4-38
bibr24-1744-8069-4-38
Watkins LR (bibr4-1744-8069-4-38) 2003; 521
bibr3-1744-8069-4-38
bibr33-1744-8069-4-38
bibr29-1744-8069-4-38
bibr8-1744-8069-4-38
bibr16-1744-8069-4-38
bibr25-1744-8069-4-38
bibr32-1744-8069-4-38
bibr38-1744-8069-4-38
bibr9-1744-8069-4-38
bibr10-1744-8069-4-38
bibr34-1744-8069-4-38
bibr13-1744-8069-4-38
bibr17-1744-8069-4-38
bibr18-1744-8069-4-38
bibr31-1744-8069-4-38
bibr22-1744-8069-4-38
References_xml – volume: 150
  start-page: 1267
  year: 1997
  end-page: 1274
  article-title: Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease
  publication-title: Am J Pathol
  contributor:
    fullname: Hyman
– volume: 104
  start-page: 92
  year: 2000
  end-page: 97
  article-title: Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis
  publication-title: J Neuroimmunol
  contributor:
    fullname: Harrison
– volume: 85
  start-page: 154
  year: 2005
  end-page: 159
  article-title: Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes
  publication-title: Lab Invest
  contributor:
    fullname: Span
– volume: 31
  start-page: e73
  year: 2003
  article-title: Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Foster
– volume: 165
  start-page: 1044
  year: 2000
  end-page: 1052
  article-title: Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression
  publication-title: J Immunol
  contributor:
    fullname: Brandt
– volume: 22
  start-page: 312
  year: 2006
  end-page: 322
  article-title: Differential regulation of the CXCR2 chemokine network in rat brain trauma: Implications for neuroimmune interactions and neuronal survival
  publication-title: Neurobiol Dis
  contributor:
    fullname: Ronken
– volume: 84
  start-page: 287
  year: 2006
  end-page: 297
  article-title: G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm
  publication-title: Can J Physiol Pharmacol
  contributor:
    fullname: Barbaz
– volume: 22
  start-page: 39
  year: 2005
  end-page: 49
  article-title: Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons
  publication-title: Eur J Neurosci
  contributor:
    fullname: Ranscht
– volume: 107
  start-page: 469
  year: 2007
  end-page: 477
  article-title: Systemic antiinflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting, and elevation of proinflammatory cytokines in a rat model of neuropathic pain
  publication-title: Anesthesiology
  contributor:
    fullname: Zhang
– volume: 71
  start-page: 600
  year: 2003
  end-page: 607
  article-title: Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia
  publication-title: J Neurosci Res
  contributor:
    fullname: Gendelman
– volume: 134
  start-page: 1399
  year: 2005
  end-page: 1411
  article-title: Chemical mediators enhance the excitability of unmyelinated sensory axons in normal and injured peripheral nerve of the rat
  publication-title: Neuroscience
  contributor:
    fullname: Tracey
– volume: 132
  start-page: 365
  year: 2000
  end-page: 386
  article-title: Primer3 on the WWW for general users and for biologist programmers
  publication-title: Methods Mol Biol
  contributor:
    fullname: Skaletsky
– volume: 26
  start-page: 246
  year: 2006
  end-page: 255
  article-title: Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha
  publication-title: J Neurosci
  contributor:
    fullname: Gereau
– volume: 521
  start-page: 1
  year: 2003
  end-page: 21
  article-title: Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain
  publication-title: Adv Exp Med Biol
  contributor:
    fullname: Maier
– volume: 95
  start-page: 14500
  year: 1998
  end-page: 14505
  article-title: Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  contributor:
    fullname: Miller
– volume: 67
  start-page: 267
  year: 1999
  end-page: 282
  article-title: Differential role of GDNF and NGF in the maintenance of two TTX-resistant sodium channels in adult DRG neurons
  publication-title: Brain Res Mol Brain Res
  contributor:
    fullname: Waxman
– volume: 95
  start-page: 1478
  year: 2006
  end-page: 1490
  article-title: Chronic IL-1beta signaling potentiates voltage-dependent sodium currents in trigeminal nociceptive neurons
  publication-title: J Neurophysiol
  contributor:
    fullname: Simon
– volume: 20
  start-page: 2627
  year: 2006
  end-page: 2629
  article-title: Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells
  publication-title: Faseb J
  contributor:
    fullname: Brack
– volume: 26
  start-page: 123
  year: 2004
  end-page: 134
  article-title: Gating and modulation of presumptive NaV1.9 channels in enteric and spinal sensory neurons
  publication-title: Mol Cell Neurosci
  contributor:
    fullname: Delmas
– volume: 126
  start-page: 810
  year: 1999
  end-page: 818
  article-title: Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha
  publication-title: Br J Pharmacol
  contributor:
    fullname: Giles
– volume: 361
  start-page: 184
  year: 2004
  end-page: 187
  article-title: Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia
  publication-title: Neurosci Lett
  contributor:
    fullname: Kress
– volume: 158
  start-page: 2882
  year: 1997
  end-page: 2890
  article-title: Expression of chemokine receptors by subsets of neurons in the central nervous system
  publication-title: J Immunol
  contributor:
    fullname: Peiper
– volume: 449
  start-page: 76
  year: 2004
  end-page: 87
  article-title: Electrophysiological characterization of the tetrodotoxin-resistant Na+ channel, Na(v)1.9, in mouse dorsal root ganglion neurons
  publication-title: Pflugers Arch
  contributor:
    fullname: Ogata
– volume: 88
  start-page: 365
  year: 2002
  end-page: 377
  article-title: Molecular diversity of structure and function of the voltage-gated Na+ channels
  publication-title: Jpn J Pharmacol
  contributor:
    fullname: Ohishi
– volume: 21
  start-page: 5027
  year: 2001
  end-page: 5035
  article-title: Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons
  publication-title: J Neurosci
  contributor:
    fullname: Miller
– volume: 12
  start-page: 1059
  year: 2008
  end-page: 1068
  article-title: Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice
  publication-title: Eur J Pain
  contributor:
    fullname: Cunha
– volume: 82
  start-page: 51
  year: 2005
  end-page: 62
  article-title: CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons
  publication-title: J Neurosci Res
  contributor:
    fullname: Wang
– volume: 10
  start-page: 40
  year: 2004
  end-page: 52
  article-title: Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia
  publication-title: Neuroscientist
  contributor:
    fullname: Tawfik
– volume: 19
  start-page: RC43
  year: 1999
  article-title: A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons
  publication-title: J Neurosci
  contributor:
    fullname: Waxman
– volume: 1029
  start-page: 251
  year: 2004
  end-page: 258
  article-title: Tetrodotoxin-sensitive and -resistant Na+ channel currents in subsets of small sensory neurons of rats
  publication-title: Brain Res
  contributor:
    fullname: Pan
– volume: 107
  start-page: 322
  year: 2007
  end-page: 332
  article-title: Local inflammation in rat dorsal root ganglion alters excitability and ion currents in small-diameter sensory neurons
  publication-title: Anesthesiology
  contributor:
    fullname: Zhang
– volume: 131
  start-page: 243
  year: 2007
  end-page: 257
  article-title: The roles of sodium channels in nociception: Implications for mechanisms of pain
  publication-title: Pain
  contributor:
    fullname: Waxman
– volume: 8
  start-page: 559
  year: 2002
  end-page: 572
  article-title: CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development
  publication-title: J Neurovirol
  contributor:
    fullname: Ragozzino
– volume: 128
  start-page: 77
  year: 2001
  end-page: 81
  article-title: Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells
  publication-title: Brain Res Dev Brain Res
  contributor:
    fullname: Stangel
– volume: 74
  start-page: 286
  year: 2003
  end-page: 295
  article-title: Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, gamma-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: a single-cell reverse transcription-multiplex polymerase chain reaction study
  publication-title: J Neurosci Res
  contributor:
    fullname: Williams
– volume: 8
  start-page: 127
  year: 2007
  end-page: 136
  article-title: Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw
  publication-title: J Pain
  contributor:
    fullname: Mitchell
– volume: 112
  start-page: 116
  year: 2006
  end-page: 138
  article-title: Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?
  publication-title: Pharmacol Ther
  contributor:
    fullname: Ferreira
– volume: 142
  start-page: 809
  year: 2006
  end-page: 822
  article-title: Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia
  publication-title: Neuroscience
  contributor:
    fullname: Zhang
– volume: 158
  start-page: 2882
  year: 1997
  ident: bibr11-1744-8069-4-38
  publication-title: J Immunol
  doi: 10.4049/jimmunol.158.6.2882
  contributor:
    fullname: Horuk R
– ident: bibr3-1744-8069-4-38
  doi: 10.1016/j.neuroscience.2005.05.046
– ident: bibr13-1744-8069-4-38
  doi: 10.1016/S0165-5728(99)00266-0
– ident: bibr22-1744-8069-4-38
  doi: 10.1016/S0169-328X(99)00070-4
– ident: bibr28-1744-8069-4-38
  doi: 10.1016/j.mcn.2004.01.015
– ident: bibr8-1744-8069-4-38
  doi: 10.1016/j.neuroscience.2006.06.045
– ident: bibr24-1744-8069-4-38
  doi: 10.1016/j.brainres.2004.09.051
– volume: 521
  start-page: 1
  year: 2003
  ident: bibr4-1744-8069-4-38
  publication-title: Adv Exp Med Biol
  contributor:
    fullname: Watkins LR
– ident: bibr21-1744-8069-4-38
  doi: 10.1096/fj.06-6077fje
– ident: bibr27-1744-8069-4-38
  doi: 10.1093/nar/gng073
– ident: bibr37-1744-8069-4-38
  doi: 10.1038/sj.bjp.0702329
– ident: bibr34-1744-8069-4-38
  doi: 10.4049/jimmunol.165.2.1044
– ident: bibr16-1744-8069-4-38
  doi: 10.1016/S0165-3806(01)00128-6
– ident: bibr38-1744-8069-4-38
  doi: 10.1523/JNEUROSCI.19-24-j0001.1999
– ident: bibr20-1744-8069-4-38
  doi: 10.1016/j.jpain.2006.06.010
– ident: bibr32-1744-8069-4-38
  doi: 10.1152/jn.00509.2005
– ident: bibr36-1744-8069-4-38
  doi: 10.1139/y05-127
– ident: bibr14-1744-8069-4-38
  doi: 10.1002/jnr.10744
– ident: bibr31-1744-8069-4-38
  doi: 10.1016/j.ejpain.2008.02.003
– ident: bibr35-1744-8069-4-38
  doi: 10.1080/13550280290100932
– ident: bibr18-1744-8069-4-38
  doi: 10.1523/JNEUROSCI.21-14-05027.2001
– ident: bibr25-1744-8069-4-38
  doi: 10.1038/labinvest.3700208
– ident: bibr23-1744-8069-4-38
  doi: 10.1111/j.1460-9568.2005.04186.x
– ident: bibr19-1744-8069-4-38
  doi: 10.1002/jnr.20612
– volume: 132
  start-page: 365
  year: 2000
  ident: bibr26-1744-8069-4-38
  publication-title: Methods Mol Biol
  contributor:
    fullname: Rozen S
– ident: bibr30-1744-8069-4-38
  doi: 10.1254/jjp.88.365
– ident: bibr33-1744-8069-4-38
  doi: 10.1002/jnr.10503
– ident: bibr15-1744-8069-4-38
  doi: 10.1073/pnas.95.24.14500
– ident: bibr9-1744-8069-4-38
  doi: 10.1097/01.anes.0000278907.37774.8d
– ident: bibr5-1744-8069-4-38
  doi: 10.1177/1073858403259950
– ident: bibr17-1744-8069-4-38
  doi: 10.1016/j.nbd.2005.11.015
– ident: bibr6-1744-8069-4-38
  doi: 10.1523/JNEUROSCI.3858-05.2006
– ident: bibr7-1744-8069-4-38
  doi: 10.1097/01.anes.0000270761.99469.a7
– volume: 150
  start-page: 1267
  year: 1997
  ident: bibr12-1744-8069-4-38
  publication-title: Am J Pathol
  contributor:
    fullname: Xia M
– ident: bibr2-1744-8069-4-38
  doi: 10.1016/j.neulet.2003.12.007
– ident: bibr10-1744-8069-4-38
  doi: 10.1016/j.pharmthera.2006.04.001
– ident: bibr1-1744-8069-4-38
  doi: 10.1016/j.pain.2007.07.026
– ident: bibr29-1744-8069-4-38
  doi: 10.1007/s00424-004-1315-0
SSID ssj0037061
Score 2.2058277
Snippet Background: Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain,...
Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through...
Background: Altered Na + channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological...
BACKGROUNDAltered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain,...
BACKGROUND: Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain,...
Abstract Background Altered Na+ channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of...
SourceID doaj
pubmedcentral
biomedcentral
proquest
crossref
pubmed
sage
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 38
SubjectTerms Animals
Chemokine CXCL1 - genetics
Chemokine CXCL1 - metabolism
Female
Ganglia, Spinal - metabolism
Immunohistochemistry
Patch-Clamp Techniques
Rats
Rats, Sprague-Dawley
Receptors, Interleukin-8B - metabolism
Sensory Receptor Cells - metabolism
Sensory Receptor Cells - physiology
Sodium - metabolism
Sodium Channels - physiology
Up-Regulation
SummonAdditionalLinks – databaseName: BioMedCentral
  dbid: RBZ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSIhLRVseCxR8qOAUNYkdP7i1K6oKUU5UWnGx_ApdsUmqJiuxR_45YyehpAsnjklsy86Mx994xp8ROrJFTq13RSK5EwnVKdhBw7NEOCetFcbaeL7i4jM7v6QfF8Xidr_jTgQ_E-wYIDMFO8pkQhMi7qMHeaA4D3756dfR5hKe9syoY9mBnnG7_p1z7avJchRZ-_8GNbczJv9I-4or0dljtDtASHzSy3wP3fP1Pjo4qcF9rjb4LY5JnXG3fB89vBhi5wfoJ2gEBhFVzXd4xvPF_FN2_A288O4KxxMt3uGmtg1olMfLOqDJ1re4bdxyXWHb8zi1WNcORxLM0Af_wy67nul7A3VwW-nVCoPKVSHLBrfgIzc3m6F8-wRdnn34Mj9PhgsYEgPApUsEgKXSSJuFG9MJ8bmVPvMZdZlj3gpLOCeldQAyeO5Kp50oTOqJLa2hhmWGPEU7dVP75wgHIEVcAGPMU5ZnWhdFSVPBpRZCWzND7ydyUdc92YYK9NfTLzATVRCqCkJVVBExQ-9GIf6uF50bwbZKngYZT1qPL0Dj1DBXlee-NDY1knhOGdWihFHJ0luwXbmW0MibUUMUTMYQYdG1b9atYjLERVMyQ896fbntjhCAfDmfIT7RpElPpl_q5VWk-wZQCpgB2jwKOqcGG9P-Y4Qv_udHvkSPxnyYnL5CO93N2h8C6OrM6zjffgH9SCv6
  priority: 500
  providerName: BioMedCentral
– databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLgpZHePpQwSnaOHZsh1tZUVWIcqLS3iy_QldsEtRkJfbIP2dsZ0ujgrhwjGNHduaz80088xmhY1uVzHpX5bVwMme6gHXQCJJL52prpbE25lecf-ZnF-zjqlrdOOorxIQleeD04hZe-MbYwtTUC8aZlo0pfN14C0AqdZ3SfEm1d6bSGkxFkZRSBWOwBvN6kmskki-uy3KWh6yUWZ77ZvZ5iir-f6KetyMob4SBxS_T6QN0f6KU-CQN5SG647tDdHTSgTvd7vAbHIM849_zQ3T3fNpLP0I_ASEYTNb23-AaL1fLT2TxFbzy8RLHDBfvcN_ZHhDm8boL7HLwAx56t9622CZdpwHrzuEoihn64H_Y9ZiUv3fQBg-t3mwwQLANUTd4AJ-5v9pN9YdH6OL0w5flWT4dyJAbIDJjLoE8Naa2JJygTqkvbe2JJ8wRx72VlgpBG-uAdIjSNU47WYGxqG2sYYYTQx-jg67v_FOEA7GiLpAz7hkvidZV1bBCilpLqa3J0LuZXdT3JL6hghz2_A7MTBWMqoJRFVNUZujt3ojX7aKzI_mtmu-DjWdPjwUAQTVBUP0Lghl6vUeIgskZdlx05_vtoHgd9kkLmqEnCS-_uyMlMGEhMiRmSJr1ZH6nW19G-W8gqcAh4JnHAXNqWnOGv4zw2f8Y4XN0bx8nU7IX6GC82vqXQMZG8yrOu19NFTVl
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: SAGE Open Access Journals
  dbid: AFRWT
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbGJiFeEGzAyrj4YYKnsCR2YocXVMrKhBhIdBN9s3wLq2iTqU0l-sg_55xcgFCQeEziOE7OJd_xOf5MyLFNYm69S4JMOBlwHYIfNCIKpHOZtdJYW6-vOP-Qnl3yd9NkukPm3VqY9guuXmBZFYyodtZo3Tgb3Zi4TE8ARnPwrWkW8IDJV-tqoZq57m5LDTyDyen1AvPaFqshN0G3tu0G2Ysh8gN72BuOP32-6Dw3E2HDr9r13pI8bj_xj9Xx895Preb-_xtg3a67_K14rP6fje-Q2y0QpcNGc-6SHV_sk4NhAUH4YkOf0bo0tJ5z3yc3z9sM_AH5DnpFkWWg_ArHdDQdvY9O3kIsX13RurDOO_qxsCXopafgfLDm3a_opMSvRFs2qBXVhaM1LwiO4fSbnVUNX_iGzgo6Wej5nL6Z6QXW6tAJRNrlctO2X90jl-PTi9FZ0G7jEBiAP1UgAXLlJrMR7rvOmI9t5iMfcRe51FtpmRAstw6giohd7rSTiQk9s7k13KSRYffJblEW_pBQhGPMIaRLPU_jSOskyXkoRaal1NYMyMueXNR1Q9mhkES7fwX0SqFQFQpVccXkgDzvhPjzvjpEkulWy9co417v9Yly-UW1Fq-88LmxocmYFzzlWubwVlnuLXjAWGfQydNOQxSYNOZpdOHL9UqlGWZXQzYgDxp9-TUcKQE_CzEgoqdJvZH0rxSzq5o0HKAtIA_o8xh1TnV29o83fPh_zY7Ira5-JuaPyG61XPvHANIq86S1rR9NUTzN
  priority: 102
  providerName: SAGE Publications
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagSIgLgpbH8vShglPoJnb8QEKorKgqxHJipb1ZfqVddZPAJit1j_xzxk62JWwRx8QP2Zlv7G8y4zFChzbPqPUuTyR3IqF6DOug4WkinJPWCmNtPF8x_cZOZ_TLPJ9fxz_1H7C50bQL90nNVst3lz83H0HhP0SFF-wISDWFlZbJhCZE3EZ3MkpoQPuUXnkUCIeNq0_auNvmr9Puy8EmFXP530RAd-Mo_wgGi_vTyQN0vyeW-LhDwkN0y1f76OC4AqO63OA3OIZ6xn_o--jutPeoH6BfgBMMgivrC3jGk_nka3p0BrZ5e47jORfvcF3ZGnDm8aIKHLPxDW5qt1iX2HbZnRqsK4djaswwBn9pF22X_3sDbXBT6uUSAxDLEHuDG7Cc69Wmr988QrOTz98np0l_LUNigM60iQAKVRhp03CPOiE-s9KnPqUudcxbYQnnpLAOqAfPXOG0E7kZe2ILa6hhqSGP0V5VV_4pwoFeERcoGvOUZanWeV7QseBSC6GtGaH3A7moH10KDhWSYg9LQD9VEKoKQlVUETFCb7dCvGoXTR7Bdmp-CjIe9B5f1Ksz1Wuw8twXxo6NJJ5TRrUoYFay8BZWtExL6OT1FiEKVDT4XXTl63WjmAze0jEZoScdXq6HIwTwYc5HiA-QNBjJsKRanMck4EBVgUlAn4cBc2qrOP-Y4bP_Du45urcNhcnoC7TXrtb-JfCt1ryKivQbYJUtcQ
  priority: 102
  providerName: Scholars Portal
Title The Chemokine CXCL1/Growth Related Oncogene Increases Sodium Currents and Neuronal Excitability in Small Diameter Sensory Neurons
URI https://journals.sagepub.com/doi/full/10.1186/1744-8069-4-38
https://www.ncbi.nlm.nih.gov/pubmed/18816377
https://search.proquest.com/docview/69640703
http://dx.doi.org/10.1186/1744-8069-4-38
https://pubmed.ncbi.nlm.nih.gov/PMC2562993
https://doaj.org/article/e7efbc0b93e7464a8fb0e9fec7942a98
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaIiEuCFoey2PxoYJTmk3sxA637YpVhViEqlasuFh-pY3YJNVmV2KP_HPGTgKEwoWLpcSJ42Q-z3wTj8cIHeskptqaJMiY4QGVE9CDikUBNybTmiut_fqKxcf07JK-XybLPZT0a2F80L5WxUm1Kk-q4trHVt6UOuzjxMJPixmYadCiJNxH-4yQ3kVv1S9hYKG67IwRT0Ng3BTUcJoFNCB-dz7OgYMw9scK99XAMPn8_X8jnbdjJ38LAPM2af4A3e_IJJ62nX6I9mx1iI6mFTjS5Q6_xj680_83P0R3F90s-hH6DtjAIKyy_grHeLacfYjCK_DHN9fYr22xBteVrgFbFheV45WNbXBTm2JbYt1mdGqwrAz26TBdH-w3XWzanN87uAc3pVytMICvdPE2uAFvuV7vuuubR-hy_u5idhZ0WzEECijMJuBAm3KV6cjtnU6IjXVmIxtRE5nUaq7he5JcG6AbLDa5kYYnamKJzrWiKo0UeYwOqrqyTxF2lIoYR8tSS9M4kjJJcjrhLJOcS61G6O1ALuKmTbshXCLsYQ2MSeHkK5x8BRWEj9CbXog_7_NuDk9vXXnqZDxo3Z-o11eiA5uwzOZKT1RGLKMplTyHt8pyq0GLxTKDRl71CBEwLN1ci6xsvW1EmrkZ0gkZoSctXn51p8PfCLEBkgY9GdbAOPCJvzvcj9Cxw5zotE3zjzd89t8PeI7u9WExMX2BDjbrrX0J3GujxujOdH7--WLs_11AuaAcyvPTL2M_Cn8AI803KQ
link.rule.ids 108,230,315,733,786,790,870,891,2115,2236,21994,24346,24965,27886,27957,27958,44980,45368,53827,53829,76169,76170
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Jj9MwFLagIwEXBDMsZRsfRnAKk8SO7XArZUqBdpBoR_RmeQsT0Saoi0SP_HOe02QgFCSOiR3Lzlv8Pfv5M0InJompcTYJUm5FQFUIflDzKBDWpsYIbUx1vmJ8zoYX9P0smdVLF_4sTP0HVy99WhX0qHLWV9Yt2CkgaApulaUBDYi4jg5oQpjooIPe4NPnaeOECQ93VKlN7Zqvcb-FPw66z1vzU0Xj_zfsuZ9C-VseWDU1De6g2zWmxL2dEtxF11xxiI56BcTTiy1-jqssz2r5_BDdGNeb6UfoB6gI9oQB5Vd4xv1ZfxSdvoWwfH2Jqxw5Z_HHwpSgYg6DH_Hp626FJ6XNNwtcEzutsCosrig-fB_Ovpt8vaP-3uK8wJOFms_xm1wtfNoNnkDQXC63df3VPXQxOJv2h0F9I0OgAcmsAwHoKdOpifwV6oS42KQuchG1kWXOCEM4J5mxgDp4bDOrrEh06IjJjKaaRZrcR52iLNxDhD2yItajM-YoiyOlkiSjoeCpEkIZ3UWvWnKR33bsG9LzYbdLQEWkF6r0QpVUEtFFLxohXn1XRTuC7dV87WXcar16US6_yNp4peMu0ybUKXGcMqpEBqNKM2fAmcUqhUaOGw2RYJ1-y0UVrtysJEv9RmlIuujBTl9-dUcIgMKcdxFvaVKrJ-2SIr-s-L8BpQKIgDZPvM7JxmT-McJH_1ftGN0cTscjOXp3_uExutWkxcT0Ceqslxv3FLDXWj-r7ewnCOkqMQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Jb9QwFLbKVKq4IGhZhq0-VHAKTWIntuE0TDsUaAtiWjE3y1toxExSzSIxR_45z1mAMCBxTOI8Pect_hw_f0bowCQxNc4mgWCWB1SFkAc1iwJurTCGa2Oq_RVn5-nJJX03SSZb6FW7F6b5gosXvqwKNKqStY_ua5vVEc7TQ0DRFFJrKgIaEH4DbVMqeNhD24PRp88XbSImLKzpUtvWDWfjpoQ_NrtPO2NUReX_N_y5WUb5Wy1YNTyNbqNbDa7Eg9oR7qAtV-yivUEBc-rZGj_DVaVn9Qt9F-2cNQvqe-g7uAn2pAHlV7jGw8nwNDp8A1Pz5RWu6uScxR8KU4KbOQy5xJewuwUelzZfzXBD7rTAqrC4ovnwOhx_M_mypv9e47zA45maTvFRrma-9AaPYeJcztdN-8VddDk6vhieBM2pDIEGNLMMOCCoTAsT-WPUCXGxES5yEbWRTZ3hhjBGMmMBebDYZlZZnujQEZMZTXUaaXIP9YqycA8Q9uiKWI_QUkfTOFIqSTIaciYU58roPnrZsYu8rhk4pOfE7j4BN5HeqNIbVVJJeB89b434871qxsPTjZavvY070qsb5fyLbAJYOuYybUItiGM0pYpn0CuROQMJLVYChOy3HiIhQv2yiypcuVrIVPjF0pD00f3aX36pwznAYcb6iHU8qaNJ90mRX1Uc4IBUAUiAzAPvc7INm3_08OH_NdtHOx-PRvL07fn7R-hmWxkT08eot5yv3BOAX0v9tAmzH1BiK0E
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+chemokine+CXCL1%2Fgrowth+related+oncogene+increases+sodium+currents+and+neuronal+excitability+in+small+diameter+sensory+neurons&rft.jtitle=Molecular+pain&rft.au=Wang%2C+Jun-Gang&rft.au=Strong%2C+Judith+A&rft.au=Xie%2C+Wenrui&rft.au=Yang%2C+Rui-Hua&rft.date=2008-09-24&rft.eissn=1744-8069&rft.volume=4&rft.spage=38&rft.epage=38&rft_id=info:doi/10.1186%2F1744-8069-4-38&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1744-8069&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1744-8069&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1744-8069&client=summon